0001437749-17-017238.txt : 20171018
0001437749-17-017238.hdr.sgml : 20171018
20171018144657
ACCESSION NUMBER: 0001437749-17-017238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171016
FILED AS OF DATE: 20171018
DATE AS OF CHANGE: 20171018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arrow Alexander K.
CENTRAL INDEX KEY: 0001497166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51353
FILM NUMBER: 171142520
MAIL ADDRESS:
STREET 1: PO BOX 3094
CITY: REDWOOD CITY
STATE: CA
ZIP: 94064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new
CENTRAL INDEX KEY: 0001022899
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 061390025
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 994-8200
MAIL ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: Atrinsic, Inc.
DATE OF NAME CHANGE: 20090630
FORMER COMPANY:
FORMER CONFORMED NAME: NEW MOTION, INC.
DATE OF NAME CHANGE: 20070504
FORMER COMPANY:
FORMER CONFORMED NAME: MPLC, Inc.
DATE OF NAME CHANGE: 20050608
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-10-16
0001022899
Protagenic Therapeutics, Inc.\new
PTIX
0001497166
Arrow Alexander K.
149 FIFTH AVENUE, SUITE 500
NEW YORK
NY
10010
1
Chief Financial Officer
Non-Qualified Stock Options (Right to Buy)
1.75
2017-10-16
4
A
0
75000
0
A
2027-10-16
Protagenic Therapeutics, Inc. Common Stock
75000
75000
D
Vesting in equal installments over 36 months, full vesting upon change of control
/s/ Alexander K. Arrow
2017-10-17